- Home
- REVB vs IMTE Comparison
REVB vs IMTE Comparison
Compare REVB & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- IMTE
- Stock Information
- Founded
- REVB 2020
- IMTE 2008
- Country
- REVB United States
- IMTE Malaysia
- Employees
- REVB N/A
- IMTE N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- IMTE Consumer Electronics/Appliances
- Sector
- REVB Health Care
- IMTE Consumer Staples
- Exchange
- REVB Nasdaq
- IMTE Nasdaq
- Market Cap
- REVB 3.4M
- IMTE 3.3M
- IPO Year
- REVB N/A
- IMTE N/A
- Fundamental
- Price
- REVB $1.53
- IMTE $1.11
- Analyst Decision
- REVB
- IMTE
- Analyst Count
- REVB 0
- IMTE 0
- Target Price
- REVB N/A
- IMTE N/A
- AVG Volume (30 Days)
- REVB 994.9K
- IMTE 1.2M
- Earning Date
- REVB 11-07-2025
- IMTE 09-26-2025
- Dividend Yield
- REVB N/A
- IMTE N/A
- EPS Growth
- REVB N/A
- IMTE N/A
- EPS
- REVB N/A
- IMTE N/A
- Revenue
- REVB N/A
- IMTE $123,337.00
- Revenue This Year
- REVB N/A
- IMTE N/A
- Revenue Next Year
- REVB N/A
- IMTE N/A
- P/E Ratio
- REVB N/A
- IMTE N/A
- Revenue Growth
- REVB N/A
- IMTE 4.75
- 52 Week Low
- REVB $1.35
- IMTE $0.51
- 52 Week High
- REVB $60.48
- IMTE $3.17
- Technical
- Relative Strength Index (RSI)
- REVB 35.53
- IMTE 53.13
- Support Level
- REVB $1.40
- IMTE $1.10
- Resistance Level
- REVB $1.59
- IMTE $1.18
- Average True Range (ATR)
- REVB 0.09
- IMTE 0.11
- MACD
- REVB 0.03
- IMTE 0.00
- Stochastic Oscillator
- REVB 44.90
- IMTE 39.01
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.